Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-18

Clinical Trial Update: The Safety and Efficacy of Recombinant Human Prolactin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of recombinant human prolactin in healthy individuals has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recombinant Human Prolactin (prolactin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Healthy | Phase 2 | Status: COMPLETED | Results posted: 2013-04-18